- Staat
- WA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 24.07.2023
- Impfdatum
- 09.05.2023
- Beginn
- 10.05.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
C-reactive protein normal
Full blood count
HIV test negative
Hepatitis C test negative
Hypoaesthesia
Cough
Eosinophil count abnormal
Fatigue
Influenza like illness
Immunology test normal
Laboratory test abnormal
Metabolic function test
Paraesthesia
Laboratory test normal
Malaise
Reversed hot-cold sensation
Sinusitis
Red blood cell sedimentation rate normal
Symptomtext
Shortly after injection patient developed flu-like symptoms. A day or two later he developed numbness and tingling in his upper extremities. This continued for several months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- CRP, ESR, CMP, CBC completed 6/5/23. All normal except mildly elevated eosinophil. B12, immunofixation serum, HIV, Hep C, B1, B6 checked 6/29/23, all normal.
- Aktuelle Erkrankungen
- Allergies
- Vorgeschichte
- Chronic Migraine secondary to head trauma.
- Andere Medikamente
- Montelukast, Vyepti
- Allergien
- Morphine, amoxicillin, duloxetine, valproic acid, zonisamide
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 24.07.2023
- Impfdatum
- 09.05.2023
- Beginn
- 10.05.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
C-reactive protein normal
Full blood count
HIV test negative
Hepatitis C test negative
Hypoaesthesia
Cough
Eosinophil count abnormal
Fatigue
Influenza like illness
Immunology test normal
Laboratory test abnormal
Metabolic function test
Paraesthesia
Laboratory test normal
Malaise
Reversed hot-cold sensation
Sinusitis
Red blood cell sedimentation rate normal
Symptomtext
Shortly after injection patient developed flu-like symptoms. A day or two later he developed numbness and tingling in his upper extremities. This continued for several months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- CRP, ESR, CMP, CBC completed 6/5/23. All normal except mildly elevated eosinophil. B12, immunofixation serum, HIV, Hep C, B1, B6 checked 6/29/23, all normal.
- Aktuelle Erkrankungen
- Allergies
- Vorgeschichte
- Chronic Migraine secondary to head trauma.
- Andere Medikamente
- Montelukast, Vyepti
- Allergien
- Morphine, amoxicillin, duloxetine, valproic acid, zonisamide
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 13.06.2023
- Impfdatum
- 12.06.2023
- Beginn
- 12.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Headache
Injected limb mobility decreased
Pyrexia
Symptomtext
Patient presented to pharmacy yesterday for a second dose of a shingrix. I noticed he qualified for Pneumovax23 so I recommended it and he agreed to get both vaccines on the same day. He received Pneomovax23 in his right arm and felt good when he left the pharmacy yesterday post administration. Today he came in to let me know that he had to go to the ER overnight due adverse reactions he felt including : fever,chills,headache and and inability to raise his right arm. He stated he was starting to feel better today but his arm still has limited mobility. He was NOT upset but thought I should be made aware of the reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKOWN
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 23.03.2023
- Beginn
- 03.04.2023
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arthritis bacterial
C-reactive protein increased
Chills
Full blood count abnormal
Joint range of motion decreased
Mobility decreased
Monocyte count increased
Muscular weakness
Nausea
Osteoarthritis
Pain in extremity
Pyrexia
Red blood cell sedimentation rate increased
Vomiting
White blood cell count increased
X-ray limb abnormal
Symptomtext
Patient verbalized fever, nausea, sore arm, trouble mobilizing arm, chills, vomiting, decreased range of motion, weak arm, and pain in her arm. Patient treated with Tylenol, heat, and ice. X-ray of right shoulder, CBC, CRP, and sed rate were ordered at visit on 3/29/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- 5,0
- Labordaten
- All completed on 3/29/2023: X-ray right shoulder: Per result, " mild degenerative changes, nothing acute." CBC: WBCs elevated at 11.9 10*3/uL, monocytes elevated at 11.9 10*3/uL CRP: Elevated at 124.3 mg/L Sed rate: Elevated at 33 mm/hr
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Overactive bladder, cough, gastroesophageal reflux disease, osteopenia, hemorrhoids, screening for breast cancer, need for shingles vaccine, leg pain anterior left, COVID Patient currently hospitalized with pyogenic arthritis of right shoulder region due to unspecified organism.
- Andere Medikamente
- Hydrocortisone 2.5% rectal cream twice daily for 10 days, calcium carbonate (calcium 500 oral) daily, turmeric oral daily, polyethylene glycol 17 g per dose powder, acetaminophen 325 mg oral Q6 hr as needed, ascorbic acid/multivitamin 1 pac
- Allergien
- Ciprofloxacin, morphine, codeine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 15.02.2023
- Impfdatum
- 10.02.2023
- Beginn
- 11.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Mobility decreased
Muscle tightness
Pain
Symptomtext
Patient received a dose of pneumovax23 on 11/29/2022; She received another dose on 2/10/23. On 2/11/23 she started experiencing pain, redness and muscle tightness (says unable to move the arm) and the symptoms continued after. she says it doesnt seem to be getting worse but is not getting much better either.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Alendronate 70mg, Sertraline 25mg, Hydroxyzine 10mg, Tramadol 50mg, Rosuvastatin 5mg, Lisinopril 10mg
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 26.07.2023
- Impfdatum
- 17.07.2023
- Beginn
- 17.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation reaction
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Pain
Peripheral swelling
Symptomtext
Pt stated he started to have the right upper arm swollen with pain after Pneumonia shot. Right upper arm: Swelling (warm and erythematous; along biceps to deltoid) and tenderness present. Visit Diagnoses Redness and swelling of upper arm - Primary Relevant Medications amoxicillin 500 MG Oral capsule naproxen sodium 275 MG Oral tablet Adverse reaction to pneumococcal vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Bladder cancer
- Andere Medikamente
- amLODIPine 10 MG Oral tablet, Atorvastatin Calcium 40 MG Oral Tab, oxyCODONE ER 18 MG Oral Capsule Extended Release 12 hour Abuse-Deterrent, oxyCODONE HCl 10 MG Oral Tab
- Allergien
- Cyclobenzaprine
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 26.07.2023
- Impfdatum
- 17.07.2023
- Beginn
- 17.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation reaction
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Pain
Peripheral swelling
Symptomtext
Pt stated he started to have the right upper arm swollen with pain after Pneumonia shot. Right upper arm: Swelling (warm and erythematous; along biceps to deltoid) and tenderness present. Visit Diagnoses Redness and swelling of upper arm - Primary Relevant Medications amoxicillin 500 MG Oral capsule naproxen sodium 275 MG Oral tablet Adverse reaction to pneumococcal vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Bladder cancer
- Andere Medikamente
- amLODIPine 10 MG Oral tablet, Atorvastatin Calcium 40 MG Oral Tab, oxyCODONE ER 18 MG Oral Capsule Extended Release 12 hour Abuse-Deterrent, oxyCODONE HCl 10 MG Oral Tab
- Allergien
- Cyclobenzaprine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 08.03.2023
- Impfdatum
- 07.03.2023
- Beginn
- 07.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Symptomtext
SORE ARM.! PATIENT USED IBUPROFEN AND AN ICE PACK
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE, ACID REFLUX, HIGH CHOLESEROL
- Andere Medikamente
- CENTRUM, PRILOSEC
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 07.03.2023
- Impfdatum
- 01.03.2023
- Beginn
- 03.03.2023
- Tage bis Beginn
- 2,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal discomfort
Asthenia
Injection site erythema
Injection site reaction
Malaise
Pyrexia
Symptomtext
Patient received vaccine 3/1 and stared having reaction described as redness, bullseye-appearing mark 1-2 inches below the injection site. Low grade fever 99F on 3/3, slight body weakness. On 3/4 awoke with 104.4F fever, worsening malaise, stomach upset, HR > 125, bordering need for ED visit. On 3/5 started to feel better, gain energy back and reported to pharmacy on 3/6.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/a
- Aktuelle Erkrankungen
- Immunocompromised [D84.9], Malignant neoplasm of mediastinum, part unspecified [C38.3], Secondary malignancy of heart [C79.89], undergoing chemotherapy regimen gemcitabine, cisplatin, dexamethasone, aprepitant, neulasta onpro, potassium chloride, magnesium, granisetron
- Vorgeschichte
- see above
- Andere Medikamente
- gabapentin, oxycodone, cyclobenzaprine, lorazepam, prochlorperazine, chemo treatment (unknown)
- Allergien
- vicodin, dilaudid
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 02.02.2023
- Impfdatum
- 01.02.2023
- Beginn
- 01.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain in extremity
Peripheral swelling
Rash
Symptomtext
Patient presented the next day to the clinic with swelling, redness, rash, and pain in the left arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Nothing
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- Hypertension, alcohol use, marijuana use, history of drug abuse - meth.
- Andere Medikamente
- Bupropion, Cyanocobalamin, Losartan, Rosuvastatin, and Trazodone
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 18.01.2023
- Impfdatum
- 11.01.2023
- Beginn
- 12.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site bruising
Injection site erythema
Injection site reaction
Injection site swelling
Symptomtext
Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: patient called 1.14.23 to report her injection site reaction. It had formed a clear large bubble with redness and swelling. Advised patient to return to Clinic for further evaluation, but she states it was already mostly resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 06.01.2023
- Impfdatum
- 04.01.2023
- Beginn
- 05.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Injection site erythema
Injection site pain
Injection site warmth
Symptomtext
right deltoid is red, hot, tender. treatment with steroids.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypertension
- Andere Medikamente
- lisinopril
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 26.12.2022
- Impfdatum
- 19.12.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site induration
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Patient reports having a swollen, warm to the touch, where the skin near the injection site also became hard to touch. Right arm in general has been quite painful for a week now. The pain started right with the injection and was worse for the first two days following injection. Pt has been using a warm compress and taking Tylenol to help with the pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site induration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Tylenol
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 17.12.2022
- Impfdatum
- 14.12.2022
- Beginn
- 15.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Fatigue
Injection site erythema
Injection site mass
Injection site pain
Injection site swelling
Lymphadenopathy
Malaise
Peripheral swelling
Skin tightness
Symptomtext
General feeling of tiredness / sickness / weakness for 3 days. Swelling in the left arm , swelling in left lymph node under the armpit, multiple red raised lumps on left arm from injection site down to the elbow with significant swelling and tightness with pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- Lupus, Rheumatoid Arthritis, Connective Tissue Disease
- Andere Medikamente
- none reported
- Allergien
- none reported
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 14.12.2022
- Impfdatum
- 12.12.2022
- Beginn
- 13.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Skin warm
Swelling
Tenderness
Urticaria
Symptomtext
Patient received Prevnar 20 vaccination in left deltoid. Reported to pharmacy staff on 12/14/22 that on 12/13/22 he began experience a "red welt" on skin under arm near the axillary area that was tender, swollen and warm to the touch. Patients states that he has not taken anything or sought medical care for the adverse event, and that is has been stable over the last 24 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Mood disorder, anxiety, seasonal allergies, arthritis, hypertension, hypothyroidism
- Andere Medikamente
- Xanax, Mobic, Norvasc, Singulair, mirtazapine, quetiapine, levothyroxine
- Allergien
- Keflex
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 07.12.2022
- Beginn
- 07.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site swelling
Symptomtext
Redness and swelling at injection site. Doctor wrote the patient prescriptions for medrol pack, benadryl, and pepcid.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 06.12.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Hypersensitivity
Injection site bruising
Injection site erythema
Injection site pain
Injection site swelling
Peripheral swelling
Rash
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash Generalized-Severe, Additional Details: ptient has swollen red arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site bruising
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Symptomtext
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: pt states her arm swelled from the elbow to her shoulder on her left side lasted about 6 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 26.11.2022
- Impfdatum
- 21.11.2022
- Beginn
- 22.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Cellulitis
Injection site cellulitis
Symptomtext
The patient went to the emergency room who diagnosed her to have Cellulitis at the site of injection that spread to both upper extremities.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- She was prescribed clindamycin 300 mgs 1 by mouth every 8 hours for 7 days on 11/23/22 and she said he feels better and the infection is almost fully gone.
- Aktuelle Erkrankungen
- herpes
- Vorgeschichte
- high blood pressure
- Andere Medikamente
- VALACYCLOVIR 500 MG, METOPROLOL ER 100 MG, AMLODIPINE 5 MG, LOSARTAN 100 MG, HYDROCHLOROTHIAZIDE 25 MG
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.11.2022
- Impfdatum
- 16.11.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 5,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site infection
Symptomtext
Patient picked up cephalexin today. Patient reports taking cephalexin for a skin and soft tissue infection in her arm where her immunizations were administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site infection
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- duloxetine, lamotrigine, famotidine
- Allergien
- tramadol (nightmares), metformin (GI upset)
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 18.11.2022
- Impfdatum
- 16.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Insomnia
Symptomtext
PATIENT STATED THAT STARTING THE DAY AFTER VACCINATION (11/17/22) THAT SHE STARTED TO HAVE PAIN AND REDNESS AROUND INJECTION SITE. PATIENT STATED THAT PAIN WORSENED OVERNIGHT AND THAT SHE HAD TROUBLE SLEEPING DUE TO PAIN. WHEN PATIENT PRESENTED TO THE PHARMACY PHARMACIST WAS ABLE TO OBSERVE THAT REDNESS WAS 5-6 CM AROUND AND OVAL SHAPED (ELONGATED UP AND DOWN ARM).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Skin warm
Swelling
Symptomtext
Patient called 11/3/22 at approximately 3 PM. Patient reported local swelling, pain, and feeling warm to the touch starting around 10 PM on 11/2/22. Patient had been putting ice on the location.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 22.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site cellulitis
Injection site erythema
Injection site induration
Injection site oedema
Symptomtext
Redness, hardness at injection site started on 10/24/2022 after receiving vaccines at Pharmacy at on 10/23/22 Cellulitis at injection site, left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Degenerative disorder of maculla Hypertension Atrial Fibrillation Palpitations
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 16.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site nodule
Injection site reaction
Symptomtext
Patient woke up next day with an injection site reaction. Arm was red from shoulder to elbow and had an "egg sized" knot. Patient has not completed an treatment as of reporting day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Skin reaction
Skin warm
Symptomtext
The LEFT arm hurt and was a little hot...(The arm that the PneumoVax23 was given in) at around 24 hours it was noticeably very red and hot to the touch, I drew a line around it with a pen and took pictures. it extended from my deltoid to my biceps . by 36 hours it was more red and swollen. I iced it and took Advil. When I woke up that next morning the swelling had gone down and it started to feel better so I did not seek medical attention for it. I did not think it was an "emergency" that needed attention on a weekend night shift.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- mitral valve regurgitation reflux/GERD hypothyroidism
- Andere Medikamente
- L-thyroxine 112mcg omeprazole caps 20mg
- Allergien
- Ranitadine (itchy hands, feet, throat) possible morphine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 15.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Injection site erythema
Injection site swelling
Lymphadenopathy
Peripheral swelling
Symptomtext
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Lymph Node Swelling-Mild, Additional Details: NOTISABLE SWELLING OF THE LEFT ARM AND SLIGHT REDNESS, NO MOTION DIFFICULTIES.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Chills
Headache
Injection site erythema
Injection site pain
Injection site swelling
Joint range of motion decreased
Nausea
Symptomtext
Severe Left Deltoid Pain/redness /Swelling effecting ROM. Not able to abduct arm above 30 degrees, Painful flexion and extension of Left elbow Headache, chills and nausea. Onset of symptoms approximately 4-5 hours after immunization Used Cool Compresses at home along with Ibuprofen. Today given a short burst of prednisone for swelling along with cool compresses and Tylenol every 4-6 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- None performed
- Aktuelle Erkrankungen
- No Known issues
- Vorgeschichte
- Allergic Rhinitis, Anxiety, CIPD, DDD, Depression, Graves' Disease Osteopenia, Hyperlipidemia
- Andere Medikamente
- Albuterol Inhaler Lorazepam Montelukast Buspirone Citalopram Symbicort Valacyclovir Tylenol Ibuprofen
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 19.09.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
5 hrs. after shot arm was in extreme pain from end of clavicle to about 2 inches below on the arm. redness and swelling. Left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- -
- Allergien
- NKDA.
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 19.09.2022
- Impfdatum
- 30.08.2022
- Beginn
- 19.09.2022
- Tage bis Beginn
- 20,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Malaise
Peripheral swelling
Skin warm
Symptomtext
Patient stated her arm swelled and was red and hot. She also did not feel well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.12.2023
- Impfdatum
- 21.12.2023
- Beginn
- 21.12.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient was given vaccine past its expiration date which is 8/29/2023. The doctor was informed of this and no action was taken per his order.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 14.12.2023
- Impfdatum
- 18.09.2023
- Beginn
- 18.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE/no PQC.; Pharmacist called to report that a dose of PNEUMOVAX 23 that expired on 8/29/2023 was administered to a patient on 9/18/2023. Caller stated product has not had any temperature excursions. Caller stated patient has not reported any symptoms. Caller st; Information has been received from a pharmacist referred to an unspecified patient of unknown age and gender. No patient's pertinent medical history, concurrent conditions, drug reactions or allergies, nor concomitant therapies were reported. On 18-SEP-2023, the unspecified patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # U032086, expiration date 29-AUG-2023, first dose,(strength, dose, route, and anatomical location were not reported), for prophylaxis (expired vaccine used). No adverse event was reported. Follow-up information was received from a pharmacist on 07-DEC-2023. It was stated that the patient was a 44-years-old female
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.11.2023
- Impfdatum
- 25.09.2023
- Beginn
- 25.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
HCP was transferred from specialist to evaluate expired PNEUMOVAX 23(PFS) inadvertently given to a patient. HCP stated no side effects have been reported. HCP confirmed there was no T/E. HCP stated it was an MA who administered the vaccine. HCP was s; HCP was transferred from specialist to evaluate expired PNEUMOVAX 23(PFS) inadvertently given to a patient. HCP stated no side effects have been reported. HCP confirmed there was no T/E. HCP stated it was an MA who administered the vaccine. HCP was s; Information has been received from an specialist via a health care professional, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-SEP-2023, the patient was inadvertently vaccinated by a medical assistant (MA) with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 1 dose, lot #U032086, expiration date: 29-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided). No adverse effects were reported. The reporting health care professional confirmed there was no temperature excursions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 40,0
- Geschlecht
- U
- Eingang
- 10.10.2023
- Impfdatum
- 06.10.2023
- Beginn
- 06.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No AE Event; HCP called to ask about next steps regarding inadvertent administration of an expired dose of PNEUMOVAX 23. Expired 8/29/2023 and was administered 10/6/2023. Referenced post expiry memo. Request case reference 02486527. Consent to contact is yes. No; This spontaneous report was received from a nurse, concerning a 40-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On 06-OCT-2023, the patient was vaccinated with an expired dose of with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter, lot #u032086, has been verified to be valid expiration date: 29-AUG-2023) administered for prophylaxis (strength, and route of administration were not provided). No adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 06.10.2023
- Impfdatum
- 06.10.2023
- Beginn
- 06.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
VACCINE WAS EXPIRED ON 08/29/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HTN COPD
- Andere Medikamente
- ALBUTEROL HFA AMLODIPINE MELOXICAM METOPROLOL
- Allergien
- NKDA NKFA NKEA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 02.10.2023
- Impfdatum
- 31.08.2023
- Beginn
- 31.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Vaccine expired 8/29/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- CHF, CAD, Hypercholesterolemia, Osteoporosis, COPD, esophageal reflux, essential hypertension, pulmonary emphysema, AAA (mild)
- Andere Medikamente
- Albuterol, Alendronate Sodium, Plavix, Irbesartan, Multivitamin, Pantoprazole, Paroxetine, Rosuvastatin, Trelegy.
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 02.10.2023
- Impfdatum
- 31.08.2023
- Beginn
- 31.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Vaccine expired 8/29/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- CHF, CAD, Hypercholesterolemia, Osteoporosis, COPD, esophageal reflux, essential hypertension, pulmonary emphysema, AAA (mild)
- Andere Medikamente
- Albuterol, Alendronate Sodium, Plavix, Irbesartan, Multivitamin, Pantoprazole, Paroxetine, Rosuvastatin, Trelegy.
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.09.2023
- Impfdatum
- 21.09.2023
- Beginn
- 21.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Confirmed no side effects or symptoms/No additional AE/no PQC; Pharmacist called to report an expired dose of PNEUMOVAX 23 was administered to a patient.; This spontaneous report was received from a pharmacist and refers to an unknown age patient. The patient's concurrent conditions, medical history, drug allergies or reactions and concomitant therapies were not reported. On 21-SEP-2023, the patient received an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml, lot #U032086 (which was confirmed to be a valid lot # for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)), expiration date reported and confirmed to be 29-AUG-2023 (route and site of administration, strength and indication not provided) (expired product administered). It was confirmed that there were no side effects or symptoms, no additional adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 28.09.2023
- Impfdatum
- 02.09.2023
- Beginn
- 02.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Confirmed no additional AE; HCP called to report inadvertent administration of expired PNEUMOVAX 23 to a patient. The product expired on 08/29/2023 and was administered on 09/02/2023. Limited patient demographics provided. Confirmed no additional AE/PQC.; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On 02-SEP-2023, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5 mL (lot # U032086, expiration date: 29-AUG-2023) (route of administration, anatomical location not provided) as prophylaxis. It was confirmed that no additional adverse events were reported. Follow-up information was received from the pharmacist on 25-SEP-2023. The patient's identifiers were updated. The patient was a 46-year-old female. It was reported that the patient "was doing OK" and did not had adverse event. The reporter was not comfortable providing any additional patient information at the time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 61,0
- Geschlecht
- U
- Eingang
- 25.09.2023
- Impfdatum
- 19.09.2023
- Beginn
- 19.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse effects were reported; HBP called to report that a patient was inadvertently administered an expired dose of PNEUMOVAX 23. Expired 8/21/2023 and was administered on 9/19/2023. No adverse effects were reported. HCP said HCP also had questions about the potency of the dose.; This spontaneous report has been received from an official manager, regarding a 61-years-old patient of unreported gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 19-SEP-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, at a dose of 0.5 milliliters as prophylaxis (lot number: U032086, which was determined to be valid as syringe formulation, with an expiration date on 29-AUG-2023) (strength, route and anatomical location of administration were not reported) (Expired product administered). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.09.2023
- Impfdatum
- 01.09.2023
- Beginn
- 01.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No other AE and no PQC; expired dose of a PNEUMOVAX 23 SYRINGE to a patient on 09/01/2023; This spontaneous report was report was received from a health business professional (HBP) concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 01-SEP-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, lot number U032086 with expiration date 29-AUG-2023, administered as prophylaxis (dosage regimen and route of administration were not provided) (Expired product administered). No additional adverse event was reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.09.2023
- Impfdatum
- 01.09.2023
- Beginn
- 01.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No other AE and no PQC; expired dose of a PNEUMOVAX 23 SYRINGE to a patient on 09/01/2023; This spontaneous report was report was received from a health business professional (HBP) concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 01-SEP-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, lot number U032086 with expiration date 29-AUG-2023, administered as prophylaxis (dosage regimen and route of administration were not provided) (Expired product administered). No additional adverse event was reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.09.2023
- Impfdatum
- 14.09.2023
- Beginn
- 14.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No other AE and no PQC; HBP calling to report the administration of an expired dose of a PNEUMOVAX 23 SYRINGE to a patient. No symptoms or further details reported. No other AE and no PQC; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-SEP-2023, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, unk, lot #U032086, expiration date: 29-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided). On 14-SEP-2023, HBP called to report the administration of an expired dose of a PNEUMOVAX 23 SYRINGE to a patient. No symptoms or further details reported. No other AE and no PQC.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.09.2023
- Impfdatum
- 05.09.2023
- Beginn
- 05.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No further AE details; dose of expired PNEUMOVAX 23 was given to a patient; This spontaneous report was received from a medical assistant and refers to an unknown patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 05-SEP-2023, the patient was vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5ml/once, lot #U032086, expiration date: 29-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). It was reported that product has had no previous temperature excursions (TEs). There were no adverse events reported (no adverse event). This is a non-valid report due to lack of patient's identifiers.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.09.2023
- Impfdatum
- 06.09.2023
- Beginn
- 06.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; HCP called to report that a dose of PNEUMOVAX 23 that expired on 8/29/2023 was given to a patient on 9/6/2023. HCP reports no previous TEs. Permission to contact HCP given. No further AE details. No PQC.; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-SEP-2023, the patient was vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot #U032086, expiration date: 29-AUG-2023, 0.5 milliliter (route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.09.2023
- Impfdatum
- 31.08.2023
- Beginn
- 31.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; HBP calling to report the administration of an expired dose of a PNEUMOVAX 23 SYRINGE to a patient on 08/31/2023. No symptoms or further details reported. No other AE and no PQC; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 31-AUG-2023, the patient was vaccinated with the expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot #U032086, expiration date: 29-AUG-2023 (exact dose, route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 06.09.2023
- Impfdatum
- 06.09.2023
- Beginn
- 01.09.2023
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
When charting the PPV23 vaccine I noted that the vaccine had expired on 8/29/23. For some reason this dose was mixed in with the other PPV23 vaccines that expire on 10/1/23. Pt. tolerated the injection without incident and no adverse event was noted or reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Asthma
- Andere Medikamente
- Information not available.
- Allergien
- History of peanut allergy
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2023
- Impfdatum
- 27.03.2023
- Beginn
- 27.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Needle issue
Syringe issue
Symptomtext
no adverse event; needle fell of the syringe; vaccine began leaking out of the syringe; Poor quality vaccine administered; the patient received a smaller than recommended dose; patient with another dose of PNEUMOVAX 23; dripped on the patients arm; This spontaneous report was received from a pharmacist referred to a 68-year-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 27-MAR-2023, the patient was vaccinated with a smaller than recommended dose pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, also reported as 0.5 milliliter/ once, lot #U032086, expiration date: 29-AUG-2023, for prophylaxis (strength, and route of administration were not provided). The reporter stated that while the patient administered this dose of PNEUMOVAX 23 (Pre-filled syringe) the vaccine began leaking out of the syringe while reporter was pushing on the plunger to administer the vaccine. A lot of the vaccine leaked out (Syringe issue). The reporter said when she went to put the cover on the needle the entire needle fell of the syringe (Needle issue). The reporter confirmed no defects to the prefilled syringe were noted. The reporter said thought she had secured the needle on correct. The reporter discarded the syringe and so the product was not available for retrieval. No pictures were available, so no pictures were being sent. The syringe needle was attached to the syringe tip before the leaking occurred. The needle able to be attached securely to the syringe. the leaking occurred from the tip of the syringe, and between the syringe hub/Luer lock and syringe needle. When the plunger rod was being pushed forward this defect was noticed. Thus, the patient received the smaller than recommended dose, the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), dripped on the patient's arm, and the reporter then revaccinated the patient with another dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, strength, lot #, expiry date, and route of administration were not provided) due to the PFS leaking in the same visit. The product was not available for retrieval so no mailer was being sent. (Poor quality device used; Product administration error; Exposure via skin contact). There was no additional adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Needle issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 11.11.2022
- Impfdatum
- 10.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Wrong product administered
Symptomtext
The patient was scheduled for 4 vaccines, the shingrix, pnuemovax 23, fluad 65 and covid 19 booster. The fluad and pnuemovax were predrawn vaccines and required only a needle. The needles were attached to the predrawn syringes. I drew up the Covid 19 in a syringe appropriate for the patient. I then mixed the dilulent into the powdered shingrix and swirled. I picked up the predrawn syringes with needles attached and secured. I then proceeded and picked up the covid-19 booster. I didn't draw up the shingrix because I wanted to able to discern between the covid 19 and shingrix syringe. I grabbed what i thought was the shingrix vials along with the covid 19 and the two predrawn syringes and approached the patient for administration. I administered the Covid 19 to upper left arm and Pneumonia lower left. I then went to administer the shingrix but I noticed the vial was empty so I drew up from what I thought was Shingrix but it was actually Covid 19. I administered the vaccine. I thought it was Shingrix but I inadvertently brought out the covid 19 vial not the mixed Shingrix vial consequently administering a double dose. I gave the fluad lower right. When I returned to vaccine station in the back I saw the Shingles vaccine filled and realized I had taken out the wrong vial.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- Degenerative Arthritis; Diabetes and Asthma
- Vorgeschichte
- Degenerative Arthritis, Asthma and diabetes
- Andere Medikamente
- HYDROCODONE/APAP 5MG/525, MEDROL DOSE PAK AND TIZANIDINE 4MG TABLETS
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.11.2022
- Impfdatum
- 19.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
The vaccine was administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis (lot # U032086 has been verified to be a valid lot number pneumococcal vaccine, polyvalent (23-valent), expiration date reported and establish as 29-AUG-2023) (strength, dose, route of administration and anatomical location were not provided). The temperature of storage and time frame of the excursion were 29.92? Fahrenheit (F) for 200 hours respectively. If a digital data logger was involved was not reported. The vaccine did not experience a previous temperature excursion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.10.2022
- Impfdatum
- 29.09.2022
- Beginn
- 29.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
No additional AE; Customer reports the administration of 2 doses of PNEUMOVAX 23 to a Patient/ Nurse confirms both doses were 0.5mL. The first dose was administered 9/13/2022 and the second was administered 9/29/2022.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies, drug reactions or allergies were not reported. On 13-SEP-2022, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter (lot number U032086 had been verified to be a valid number; expiration date reported and established as: 29-AUG-2023). In addition, on 29-SEP-2022 (also reported as between a 2-week period), the patient received another dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) with the same lot number, both administered as prophylaxis (strengths, vaccination schemes, route of administration and anatomical location were not provided) (inappropriate schedule of product administration). No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.10.2022
- Impfdatum
- 29.09.2022
- Beginn
- 29.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
No additional AE; Customer reports the administration of 2 doses of PNEUMOVAX 23 to a Patient/ Nurse confirms both doses were 0.5mL. The first dose was administered 9/13/2022 and the second was administered 9/29/2022.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies, drug reactions or allergies were not reported. On 13-SEP-2022, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter (lot number U032086 had been verified to be a valid number; expiration date reported and established as: 29-AUG-2023). In addition, on 29-SEP-2022 (also reported as between a 2-week period), the patient received another dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) with the same lot number, both administered as prophylaxis (strengths, vaccination schemes, route of administration and anatomical location were not provided) (inappropriate schedule of product administration). No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 22.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
PPSV 23 WAS ADMINISTERED SOONER THAN RECOMENDED SCHEDULE LAST PPSV 23 WAS 10/11/2019
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- albuterol (VENTOLIN) 108 (90 Base) MCG/ACT inhaler INHALE 2 PUFFS INTO THE LUNGS EVERY 6 HOURS AS NEEDED FOR WHEEZE amLODIPine (NORVASC) 10 mg tablet Take 10 mg by mouth daily before breakfast. doxazosin (CARDURA) 4 mg tablet Take 4 mg by m
- Allergien
- Sulfa Antibiotics
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Syringe issue
Symptomtext
No aditional AE; The medicine leaked out / the medication leaked out from the syringe; Potential nurse exposure during administration to the patient; Complaint Description Detail Customer reported a malfunctioned pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe. She reported during administration on the patient's leg, the medication leaked out from the syringe. This AE is created for the patient. AE created in case 02264905 for potential nurse exposure during administration to the patient as a precaution. No PQC reported. No further information was provided. mailer sent. QUESTION SECTION: High Risk: Leaking Prior to Opening High Risk: Leaking during use from a site other than the product dispensing point Medium Risk: Leaking during use from the product dispensing point NOTE: Most MERCK prefilled syringes require a syringe needle to be attached to the hub or tip of the syringe using a Luer Lock attachment by the healthcare provider; which allows the needle to be twisted onto the tip and then locked in place. NOTE: Confirm that the syringe is not cracked or broken, including a broken or loose Luer Lock adaptor. If there is any sign of breakage, refer to the appropriate broken/cracked syringe article. Additionally, if there was difficulty attaching the syringe needle, and the leakage occurred at the syringe tip and syringe needle area of attachment, also refer to the Prefilled Syringe: Broken/Cracked Article. - For syringes when the customer must attach a needle: Was the syringe needle attached to the syringe tip before the leaking occurred? YES - If a needle was attached, was the needle able to be attached securely to the syringe? YES - If no, describe what issue was encountered while attaching the needle? - From where did the leaking occur? (select one) - From the tip of the Syringe Needle? NA - From the tip of the Syringe? NA - Between the syringe hub/Luer lock and syringe needle? YES - Base of syringe where the plunger rod/stopper is located? NA - Under what situation was this defect noticed: (select one) - While the syringe was still in the tray? NA - If yes, is there still product (liquid or residue) in the blister tray? YES/NO/NA/UNSPECIFIED - After removing the syringe from the tray? NO - While trying to attach the needle to the syringe? NO - While pulling back on the plunger rod? NO - While the plunger rod was being pushed forward? NA - Did the plunger rod/stopper come completely or partially out of the syringe barrel while pulling back on the plunger rod?YES/NO/NA/UNSPECIFIED -While giving the injection? YES -After the injection was given? NA Is there anything that is visible that could explain why the leaking occurred? (e.g. cracked barrel, malformed stopper. .. etc.?) NO Was the product administered or exposed to patient's bodily fluids(i.e. biohazardous)? YES IT LEAKED ON THE PATIENTS LEG If photos are available, ask the customer to send them to email: CALLER SAID SHE WOULD TAKE THE PICTURES AND SEND THEM Retrieval Information: Expedited Return Obtain product (& tray if possible) NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. BIO MAILER SENT Sample Tracking Number: User's Experience: Repeat User Insertion Difficulty: Not Applicable Insertion Difficulty Details: Not Applicable Doubt About Presence: Not Applicable Doubt Details: Not Applicable Migration: Not Applicable Migration Details: Not Applicable Removal Problem: Not Applicable Removal Problem Details: Not Applicable 10-OCT-2022 17:30 PM :Attachment added to System. 10-OCT-2022 17:30 PM :Attachment added to System. 10-OCT-2022 17:30 PM :Attachment added to System. 10-OCT-2022 17:30 PM :Email received in the System Contact Center Mailbox on 10-OCT-2022 at 3:09pm with a picture related to this case. Picture embedded within the email so picture was saved within a PDF file and attached separately. See attachment. 10-OCT-2022 17:30 PM :Attachment added to System. 10-OCT-2022 17:30 PM :Attachment added to System. 10-OCT-2022 17:30 PM :Case re-opened to fix the details. 10-OCT-2022: Photo received & attached 10-OCT-2022; Second person reviewed 11-OCT-2022; Second person reviewed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Device leakage
Exposure via skin contact
Symptomtext
No adverse event; Leaked on the patient's leg; during administration on the patient's leg, the medication leaked out from the syringe; the medication leaked out from the syringe; Leaked on the patient's leg; Customer reported a malfunctioned pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe. She reported during administration on the patient's leg, the medication leaked out from the syringe. This adverse event (AE) was created for the patient. AE created in case 02264905 for potential nurse exposure during administration to the patient as a precaution. No PQC reported. No further information was provided. Biomailer sent. QUESTION SECTION: High Risk: Leaking Prior to Opening High Risk: Leaking during use from a site other than the product dispensing point Medium Risk: Leaking during use from the product dispensing point NOTE: Most MERCK prefilled syringes require a syringe needle to be attached to the hub or tip of the syringe using a Luer Lock attachment by the healthcare provider; which allows the needle to be twisted onto the tip and then locked in place. NOTE: Confirm that the syringe was not cracked or broken, including a broken or loose Luer Lock adaptor. If there was any sign of breakage, refer to the appropriate broken/cracked syringe article. Additionally, if there was difficulty attaching the syringe needle, and the leakage occurred at the syringe tip and syringe needle area of attachment, also refer to the Prefilled Syringe: Broken/Cracked Article. For syringes when the customer must attach a needle: Was the syringe needle attached to the syringe tip before the leaking occurred? YES If a needle was attached, was the needle able to be attached securely to the syringe? YES If no, describe what issue was encountered while attaching the needle? From where did the leaking occur? (select one) From the tip of the Syringe Needle? NA From the tip of the Syringe? NA Between the syringe hub/Luer lock and syringe needle? YES Base of syringe where the plunger rod/stopper is located? NA Under what situation was this defect noticed: (select one) While the syringe was still in the tray? NA If yes, is there still product (liquid or residue) in the blister tray? YES/NO/NA/UNSPECIFIED After removing the syringe from the tray? NO While trying to attach the needle to the syringe? NO While pulling back on the plunger rod? NO Device Related Report Quality Customer Complaints While the plunger rod was being pushed forward? NA Did the plunger rod/stopper come completely or partially out of the syringe barrel while pulling back on the plunger rod? YES/NO/NA/UNSPECIFIED While giving the injection? YES After the injection was given? NA Is there anything that is visible that could explain why the leaking occurred? (e.g. cracked barrel, malformed stopper. .. etc.?) NO Was the product administered or exposed to patient's bodily fluids(i.e. biohazardous)? YES IT LEAKED ON THE PATIENTS LEG if photos are available, ask the customer to send them: CALLER SAID SHE WOULD TAKE THE PICTURES AND SEND THEM Retrieval Information: Expedited Return Obtain product (& tray if possible) NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. BIOMAILER SENT Sample Tracking Number: User's Experience: Repeat User Insertion Difficulty: Not Applicable Insertion Difficulty Details: Not Applicable Doubt About Presence: Not Applicable Doubt Details: Not Applicable Migration: Not Applicable Migration Details: Not Applicable Removal Problem: Not Applicable Removal Problem Details: Not Applicable 10-OCT-2022 17:30 PM :Attachment added. 10-OCT-2022 17:30 PM :Attachment added. 10-OCT-2022 17:30 PM :Attachment added. 10-OCT-2022 17:30 PM :Email received in the Contact Center Mailbox on 10-OCT-2022 at 3:09pm with a picture related to this case. Picture embedded within the email so picture was saved within a file and attached separately. See attachment. 10-OCT-2022 17:30 PM :Attachment added. 10-OCT-2022 17:30 PM :Attachment added. 10-OCT-2022 17:30 PM :Case re-opened to fix the details. 10-OCT-2022: Photo received & attached 11-OCT-2022: Second person reviewed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Device leakage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -